The controversial role of tumor necrosis factor α in fibrotic diseases
Authors:
Open Access
- 30 July 2008
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 58 (8) , 2228-2235
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- Systemic sclerosis: a prototypic multisystem fibrotic disorderJournal of Clinical Investigation, 2007
- Fatal exacerbation of fibrosing alveolitis associated with systemic sclerosis in a patient treated with adalimumabAnnals of the Rheumatic Diseases, 2006
- Renal fibrosis: New insights into the pathogenesis and therapeuticsKidney International, 2006
- Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximabBMJ, 2004
- TNF? and the TNF receptor superfamily: Structure-function relationship(s)Microscopy Research and Technique, 2000
- Molecular mechanisms of tumor necrosis factor‐induced cytotoxicityFEBS Letters, 1994
- Deficiencies in collagen phagocytosis by human fibroblasts in vitro: A mechanism for fibrosis?Journal of Cellular Physiology, 1993
- Comparative Effects of Interleukin-1 and Tumor Necrosis Factor-α on Collagen Production and Corresponding Procollagen mRNA Levels in Human Dermal FibroblastsJournal of Investigative Dermatology, 1991
- Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblastsFEBS Letters, 1990
- Tumor necrosis factor inhibits collagen and fibronectin synthesis in human dermal fibroblastsFEBS Letters, 1988